| Year |
Citation |
Score |
| 2019 |
Green DS, Nunes AT, Tosh KW, David-Ocampo V, Fellowes VS, Ren J, Jin J, Frodigh SE, Pham C, Procter J, Tran C, Ekwede I, Khuu H, Stroncek DF, Highfill SL, ... Zoon KC, et al. Production of a cellular product consisting of monocytes stimulated with Sylatron (Peginterferon alfa-2b) and Actimmune (Interferon gamma-1b) for human use. Journal of Translational Medicine. 17: 82. PMID 30871636 DOI: 10.1186/S12967-019-1822-6 |
0.338 |
|
| 2019 |
Green DS, Husain SR, Johnson CL, Sato Y, Han J, Joshi B, Hewitt SM, Puri RK, Zoon KC. Combination immunotherapy with IL-4 Pseudomonas exotoxin and IFN-α and IFN-γ mediate antitumor effects in vitro and in a mouse model of human ovarian cancer. Immunotherapy. 11: 483-496. PMID 30860437 DOI: 10.2217/Imt-2018-0158 |
0.42 |
|
| 2019 |
Duemler A, Green DS, Highfill SL, Stroncek D, Zoon K, Annunziata CM. Production of autologous monocytes stimulated ex vivo with peg-interferon alfa 2b and interferon gamma 1b for intraperitoneal administration in phase I clinical trial. Journal of Clinical Oncology. 37: 5-5. DOI: 10.1200/Jco.2019.37.8_Suppl.5 |
0.414 |
|
| 2019 |
Green DS, Johnson CL, Qi C, Tosh KW, Kamenyeva O, Zoon KC, Annunziata CM. Abstract TMIM-073: THE COMBINATION OF INTERFERONS ALPHA AND GAMMA AND MONOCYTES INDUCES OVARIAN CANCER CELL DEATH AND PROVIDE A RATIONALE FOR A NOVEL, ONGOING, IMMUNOTHERAPY PHASE 1 CLINICAL TRIAL Clinical Cancer Research. 25. DOI: 10.1158/1557-3265.Ovcasymp18-Tmim-073 |
0.423 |
|
| 2017 |
Nunes AT, Green D, Ekwede I, Zoon K, Annunziata CM. Phase 1 study of intraperitoneal infusion of autologous monocytes with peginterferon alfa-2b and interferon gamma-1b in women with recurrent or refractory ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Journal of Clinical Oncology. 35: TPS3092-TPS3092. DOI: 10.1200/Jco.2017.35.15_Suppl.Tps3092 |
0.333 |
|
| 2016 |
Bedsaul JR, Zaritsky LA, Zoon KC. Type I Interferon-Mediated Induction of Antiviral Genes and Proteins Fails to Protect Cells from the Cytopathic Effects of Sendai Virus Infection. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. PMID 27508859 DOI: 10.1089/Jir.2016.0051 |
0.505 |
|
| 2016 |
Green DS, Nunes AT, Annunziata CM, Zoon KC. Monocyte and interferon based therapy for the treatment of ovarian cancer. Cytokine & Growth Factor Reviews. PMID 27026228 DOI: 10.1016/J.Cytogfr.2016.02.006 |
0.406 |
|
| 2015 |
Zaritsky LA, Bedsaul JR, Zoon KC. Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes. Journal of Virology. 89: 11534-48. PMID 26355085 DOI: 10.1128/JVI.01727-15 |
0.365 |
|
| 2015 |
Johnson CL, Green DS, Zoon KC. Human monocytes in the presence of interferons alpha2a and gamma are potent killers of serous ovarian cancer cell lines in combination with paclitaxel and carboplatin. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 35: 55-62. PMID 25068849 DOI: 10.1089/Jir.2014.0057 |
0.502 |
|
| 2015 |
Green D, Johnson C, Zoon K. A monocyte and interferon based cell therapy for the treatment of ovarian cancer Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P222 |
0.36 |
|
| 2015 |
Balinsky CA, Schmeisser H, Ganesan S, Jin T, Singh K, Zoon KC. ID: 112 Cytokine. 76: 86. DOI: 10.1016/J.Cyto.2015.08.139 |
0.475 |
|
| 2015 |
Green DS, Johnson CL, Zoon KC. ID: 69 Cytokine. 76: 78. DOI: 10.1016/J.Cyto.2015.08.099 |
0.362 |
|
| 2015 |
Schmeisser H, Balinsky C, Singh K, Sreedhara K, Dolan M, Garboczi D, Zoon K. ID: 45 Cytokine. 76: 72. DOI: 10.1016/J.Cyto.2015.08.075 |
0.367 |
|
| 2015 |
Bedsaul J, Zaritsky L, Zoon K. ID: 31 Cytokine. 76: 69. DOI: 10.1016/J.Cyto.2015.08.061 |
0.521 |
|
| 2015 |
Zaritsky L, Bedsaul J, Zoon K. ID: 30 Cytokine. 76: 69. DOI: 10.1016/J.Cyto.2015.08.060 |
0.466 |
|
| 2014 |
Schmeisser H, Bekisz J, Zoon KC. New function of type I IFN: induction of autophagy. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 34: 71-8. PMID 24428799 DOI: 10.1089/Jir.2013.0128 |
0.458 |
|
| 2014 |
Balinsky CA, Schmeisser H, Zoon KC. 4 Cytokine. 70: 28-29. DOI: 10.1016/J.Cyto.2014.07.011 |
0.431 |
|
| 2013 |
Bekisz J, Sato Y, Johnson C, Husain SR, Puri RK, Zoon KC. Immunomodulatory effects of interferons in malignancies. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 33: 154-61. PMID 23570381 DOI: 10.1089/Jir.2012.0167 |
0.554 |
|
| 2013 |
Zoon KC. Ernest (Pete) Knight Jr. (1932-2013). A remembrance to a great interferon scientist and colleague. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 33: 97-8. PMID 23477599 DOI: 10.1089/Jir.2013.1500 |
0.439 |
|
| 2013 |
Schmeisser H, Fey SB, Horowitz J, Fischer ER, Balinsky CA, Miyake K, Bekisz J, Snow AL, Zoon KC. Type I interferons induce autophagy in certain human cancer cell lines Autophagy. 9: 683-696. PMID 23419269 DOI: 10.4161/Auto.23921 |
0.456 |
|
| 2013 |
Zaritsky LA, Zoon KC. 295 Cytokine. 63: 313. DOI: 10.1016/J.Cyto.2013.06.298 |
0.44 |
|
| 2013 |
Schmeisser H, Fey SB, Horowitz J, Fischer ER, Balinsky CA, Miyake K, Bekisz J, Snow AL, Zoon KC. 228 Cytokine. 63: 297. DOI: 10.1016/J.Cyto.2013.06.231 |
0.473 |
|
| 2013 |
Morrow A, Zoon K. 181 Cytokine. 63: 285. DOI: 10.1016/j.cyto.2013.06.184 |
0.646 |
|
| 2013 |
Johnson CL, Green DS, Bekisz J, Zoon KC. 133 Cytokine. 63: 274. DOI: 10.1016/J.Cyto.2013.06.136 |
0.473 |
|
| 2013 |
Green DS, Bekisz J, Dolan M, Zoon KC. 101 Cytokine. 63: 267. DOI: 10.1016/J.Cyto.2013.06.104 |
0.352 |
|
| 2013 |
Bekisz J, Eichberg D, Dolan M, Zhao T, Zoon KC. 18 Cytokine. 63: 247. DOI: 10.1016/J.Cyto.2013.06.021 |
0.494 |
|
| 2012 |
Miyake K, Bekisz J, Zhao T, Clark CR, Zoon KC. Apoptosis-inducing factor (AIF) is targeted in IFN-α2a-induced Bid-mediated apoptosis through Bak activation in ovarian cancer cells. Biochimica Et Biophysica Acta. 1823: 1378-88. PMID 22683989 DOI: 10.1016/J.Bbamcr.2012.05.031 |
0.376 |
|
| 2012 |
Nakashima H, Miyake K, Clark CR, Bekisz J, Finbloom J, Husain SR, Baron S, Puri RK, Zoon KC. Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors. Cancer Immunology, Immunotherapy : Cii. 61: 1081-92. PMID 22159517 DOI: 10.1007/s00262-011-1152-x |
0.385 |
|
| 2012 |
Tsuno T, Mejido J, Zhao T, Phillips T, Myers TG, Bekisz J, Zoon KC. BID is a critical factor controlling cell viability regulated by IFN-α. Journal of Immunotherapy (Hagerstown, Md. : 1997). 35: 23-31. PMID 22130162 DOI: 10.1097/Cji.0B013E3182372Dcf |
0.504 |
|
| 2012 |
Morrow A, Zoon K. P104 Novel unphosphorylated STAT-containing transcription factor complex formation induced by IFN-gamma treatment results in antiviral activity Cytokine. 59: 553. DOI: 10.1016/j.cyto.2012.06.195 |
0.717 |
|
| 2011 |
Vázquez N, Schmeisser H, Dolan MA, Bekisz J, Zoon KC, Wahl SM. Structural variants of IFNα preferentially promote antiviral functions. Blood. 118: 2567-77. PMID 21757613 DOI: 10.1182/Blood-2010-12-325027 |
0.397 |
|
| 2011 |
Baron S, Finbloom J, Horowitz J, Bekisz J, Morrow A, Zhao T, Fey S, Schmeisser H, Balinsky C, Miyake K, Clark C, Zoon K. Near eradication of clinically relevant concentrations of human tumor cells by interferon-activated monocytes in vitro. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 31: 569-73. PMID 21323569 DOI: 10.1089/Jir.2010.0153 |
0.728 |
|
| 2011 |
Morrow AN, Schmeisser H, Tsuno T, Zoon KC. A novel role for IFN-stimulated gene factor 3II in IFN-γ signaling and induction of antiviral activity in human cells. Journal of Immunology (Baltimore, Md. : 1950). 186: 1685-93. PMID 21178011 DOI: 10.4049/Jimmunol.1001359 |
0.77 |
|
| 2011 |
Zoon KC, Nakashima H, Miyake K, Clark C, Bekisz J, Baron S, Husain SR, Puri RK. CS14-7. Combination therapy with IFN-alpha plus IFN-gamma and monocytes mediates synergistic antitumor effects against established human ovarian and melanoma tumors in mouse models Cytokine. 56: 102. DOI: 10.1016/j.cyto.2011.07.397 |
0.392 |
|
| 2011 |
Miyake K, Bekisz J, Zhao T, Clark C, Zoon KC. PS2-119. Apoptosis-inducing factor (AIF) is targeted in IFN-alpha 2a-induced Bid mediated apoptosis through Bak activation in ovarian cancer cells Cytokine. 56: 97. DOI: 10.1016/J.Cyto.2011.07.286 |
0.399 |
|
| 2011 |
Bekisz J, Zhao T, Zoon KC. PS1-050 Pro-Inflammatory Cytokine Expression in Three Cell Types after Treatment with IFN-alpha subtypes as Assessed by Multiplex Assays Cytokine. 56: 29-30. DOI: 10.1016/J.Cyto.2011.07.080 |
0.404 |
|
| 2011 |
Schmeisser H, Fey SB, Horowitz J, Fischer ER, Miyake K, Balinsky CA, Bekisz J, Zoon KC. PS1-023. Human interferon-alpha2c induces autophagy in Daudi Burkitt’s lymphoma cells Cytokine. 56: 22. DOI: 10.1016/J.Cyto.2011.07.042 |
0.411 |
|
| 2010 |
Schmeisser H, Mejido J, Balinsky CA, Morrow AN, Clark CR, Zhao T, Zoon KC. Identification of alpha interferon-induced genes associated with antiviral activity in Daudi cells and characterization of IFIT3 as a novel antiviral gene. Journal of Virology. 84: 10671-80. PMID 20686046 DOI: 10.1128/Jvi.00818-10 |
0.734 |
|
| 2010 |
Bekisz J, Baron S, Balinsky C, Morrow A, Zoon KC. Antiproliferative Properties of Type I and Type II Interferon. Pharmaceuticals (Basel, Switzerland). 3: 994-1015. PMID 20664817 DOI: 10.3390/Ph3040994 |
0.778 |
|
| 2010 |
Tsuno T, Mejido J, Zhao T, Phillips T, Bekisz J, Zoon KC. SS8-7 The anti-proliferative activity of IFN-alpha mediated by BID through TRAIL Cytokine. 52: 75. DOI: 10.1016/J.Cyto.2010.07.435 |
0.419 |
|
| 2010 |
Clark CR, Schmeisser H, Mejido J, Balinsky C, Morrow A, Zhao T, Zoon K. PS2-57 Characterization of IFIT3 as a novel antiviral protein Cytokine. 52: 62. DOI: 10.1016/J.Cyto.2010.07.262 |
0.64 |
|
| 2010 |
Baron S, Finbloom J, Horowitz J, Bekisz J, Morrow A, Zhao T, Fey S, Schmeisser H, Balinski C, Zoon K. CS4-6 Antiproliferative activity of interferon activated monocytes against high concentrations of human tumor cells Cytokine. 52: 41. DOI: 10.1016/J.Cyto.2010.07.174 |
0.731 |
|
| 2010 |
Morrow A, Schmeisser H, Tsuno T, Zoon K. PS1-64 Role for ISGF3 in the antiviral activity of interferon gamma Cytokine. 52: 30-31. DOI: 10.1016/J.Cyto.2010.07.136 |
0.728 |
|
| 2009 |
Tsuno T, Mejido J, Zhao T, Schmeisser H, Morrow A, Zoon KC. IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha. Journal of Immunotherapy (Hagerstown, Md. : 1997). 32: 803-16. PMID 19752753 DOI: 10.1097/Cji.0B013E3181Ad4092 |
0.755 |
|
| 2009 |
Bekisz J, Schmeisser H, Stephany D, Zoon K. Using luminex (xMAP) technology to assay for inflammatory cytokines in cell culture supernatants from daudi and ovcar-3 cells treated with interferon Cytokine. 48: 115. DOI: 10.1016/J.Cyto.2009.07.487 |
0.341 |
|
| 2009 |
Schmeisser H, Mejido JA, Balinsky C, Zoon KC. Identification of IFN-alpha-induced genes and proteins associated with antiviral activity in daudi cells Cytokine. 48: 87. DOI: 10.1016/J.Cyto.2009.07.314 |
0.468 |
|
| 2009 |
Balinsky CA, Schmeisser H, Zoon KC. Dengue virus core protein mediates reduction of antiviral activity in Huh7 cells Cytokine. 48: 68. DOI: 10.1016/J.Cyto.2009.07.220 |
0.372 |
|
| 2009 |
Baron S, Horowitz J, Poast J, Morrow A, Fey S, Finbloom J, Schmeisser H, Bekisz J, Zoon K. Role of interferon-activated macrophages in eradication of human tumor cells by innate immunity Cytokine. 48: 48. DOI: 10.1016/J.Cyto.2009.07.134 |
0.733 |
|
| 2008 |
Baron S, Poast J, Suzuki F, Kobayashi M, Clouse K, Bacot S, Tiffany L, Lankford C, Boekhoudt G, Morrow A, Fey S, Schmeisser H, Bekisz J, Zoon K. 331 Innate immunity: Preclinical study of eradication of tumor cells by IFN-activated monocytes in vitro and in vivo Cytokine. 43: 322. DOI: 10.1016/J.Cyto.2008.07.415 |
0.746 |
|
| 2008 |
Morrow AN, Schmeisser H, Tsuno T, Zoon KC. 18 Induction of ISGF3 in response to interferon gamma in human cells Cytokine. 43: 240-241. DOI: 10.1016/J.Cyto.2008.07.058 |
0.748 |
|
| 2008 |
Schmeisser H, Mejido J, Zoon KC. 17 Identification of IFN-alpha-induced genes and proteins that are associated with antiviral activity in Daudi cells Cytokine. 43: 240. DOI: 10.1016/J.Cyto.2008.07.057 |
0.468 |
|
| 2008 |
Bekisz J, Mejido J, Veenstra T, Zoon K. 15 Gene and protein expression observed after treatment of Daudi cells with IFN-α2c and IFN-α21β Cytokine. 43: 240. DOI: 10.1016/J.Cyto.2008.07.055 |
0.473 |
|
| 2008 |
Tsuno T, Mejido J, Zhao T, Morrow A, Zoon KC. 3 Roles of JAK-STAT pathway factors in antiproliferative activities of human IFN-α and IFN-γ: A comprehensive assessment in human ovarian adenocarcinoma OVCAR3 cells Cytokine. 43: 237. DOI: 10.1016/J.Cyto.2008.07.043 |
0.763 |
|
| 2007 |
Schmeisser H, Gorshkova I, Brown PH, Kontsek P, Schuck P, Zoon KC. Two interferons alpha influence each other during their interaction with the extracellular domain of human type interferon receptor subunit 2. Biochemistry. 46: 14638-49. PMID 18027911 DOI: 10.1021/Bi7012036 |
0.453 |
|
| 2007 |
Baron S, Hernandez J, Bekisz J, Poast J, Goldman N, Clouse K, Fields K, Bacot S, Wang J, Zoon K. Clinical model: interferons activate human monocytes to an eradicative tumor cell level in vitro. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 27: 157-63. PMID 17316143 DOI: 10.1089/Jir.2006.0083 |
0.521 |
|
| 2007 |
Tsuno T, Mejido J, Schmeisser H, Fey S, Morrow A, Nie H, Zhao T, Bekisz J, Goldman N, Zoon K. 155 Synthesis of IRF-9 is Important in the Antiproliferative Response to IFN-α in Jak-Stat Signaling Pathway of OVCAR3 Cells Cytokine. 39: 43. DOI: 10.1016/J.Cyto.2007.07.160 |
0.732 |
|
| 2006 |
Schmeisser H, Kontsek P, Esposito D, Gillette W, Schreiber G, Zoon KC. Binding Characteristics of IFN-alpha Subvariants to IFNAR2-EC and Influence of the 6-Histidine Tag. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 26: 866-76. PMID 17238829 DOI: 10.1089/Jir.2006.26.866 |
0.485 |
|
| 2006 |
Van Cleve W, Amaro-Carambot E, Surman SR, Bekisz J, Collins PL, Zoon KC, Murphy BR, Skiadopoulos MH, Bartlett EJ. Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1. Virology. 352: 61-73. PMID 16750233 DOI: 10.1016/J.Virol.2006.04.011 |
0.4 |
|
| 2005 |
Hu R, Lei KJ, Bekisz J, Zoon KC. Protein engineering of interferon alphas. Methods in Molecular Medicine. 116: 69-80. PMID 16000855 DOI: 10.1385/1-59259-939-7:069 |
0.444 |
|
| 2004 |
Bekisz J, Schmeisser H, Hernandez J, Goldman ND, Zoon KC. Human interferons alpha, beta and omega. Growth Factors (Chur, Switzerland). 22: 243-51. PMID 15621727 DOI: 10.1080/08977190400000833 |
0.485 |
|
| 2002 |
Schmeisser H, Hu R, Kontsek P, Bekisz J, Zoon K. Amino acid substitutions in loop BC and helix C affect antigenic properties of helix D in hybrid IFN-alpha21a/alpha2c molecules. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 22: 463-72. PMID 12034029 DOI: 10.1089/10799900252952253 |
0.475 |
|
| 2001 |
Meager A, Gaines Das R, Zoon K, Mire-Sluis A. Establishment of new and replacement World Health Organization International Biological Standards for human interferon alpha and omega. Journal of Immunological Methods. 257: 17-33. PMID 11687235 DOI: 10.1016/S0022-1759(01)00460-4 |
0.345 |
|
| 1998 |
Grimley PM, Fang H, Rui H, Petricoin EF, Ray S, Dong F, Fields KH, Hu R, Zoon KC, Audet S, Beeler J. Prolonged STAT1 activation related to the growth arrest of malignant lymphoma cells by interferon-α Blood. 91: 3017-3027. PMID 9531615 DOI: 10.1182/Blood.V91.8.3017.3017_3017_3027 |
0.437 |
|
| 1997 |
Mire-Sluis AR, Gaines Das R, Zoon K, Padilla A, Thorpe R, Meager A. The biological properties, assay, and standardization of interferon-alpha: a need for a WHO collaborative study. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 16: 637-43. PMID 8877735 DOI: 10.1089/Jir.1996.16.637 |
0.401 |
|
| 1993 |
Hu R, Gan Y, Liu J, Miller D, Zoon KC. Evidence for multiple binding sites for several components of human lymphoblastoid interferon-α Journal of Biological Chemistry. 268: 12591-12595. PMID 8509399 |
0.351 |
|
| 1993 |
Hayes MP, Zoon KC. Priming of human monocytes for enhanced lipopolysaccharide responses: Expression of alpha interferon, interferon regulatory factors, and tumor necrosis factor Infection and Immunity. 61: 3222-3227. PMID 8335353 |
0.338 |
|
| 1991 |
Hayes MP, Enterline JC, Gerrard TL, Zoon KC. Regulation of interferon production by human monocytes: Requirements for priming for lipopolysaccharide-induced production Journal of Leukocyte Biology. 50: 176-181. PMID 1649241 |
0.338 |
|
| 1990 |
Weitz G, Bekisz J, Zoon K, Arnheiter H. Purification and characterization of a human Mx protein. Journal of Interferon Research. 9: 679-89. PMID 2607176 DOI: 10.1089/Jir.1989.9.679 |
0.365 |
|
| 1989 |
Bekisz JB, zur Nedden DL, Enterline JC, Zoon KC. Antibodies to interferon-alpha 2 in patients treated with interferon-alpha 2 for hairy cell leukemia Journal of Interferon Research. 9. PMID 2809275 |
0.32 |
|
| 1989 |
Webb DSA, Nedden DZ, Miller DM, Zoon KC, Gerrard TL. Enhancement of monocyte-mediated tumoricidal activity by multiple interferon-α species Cellular Immunology. 124: 158-167. PMID 2529978 DOI: 10.1016/0008-8749(89)90119-6 |
0.334 |
|
| 1989 |
Hogrefe HH, McPhie P, Bekisz JB, Enterline JC, Dyer D, Webb DSA, Gerrard TL, Zoon KC. Amino terminus is essential to the structural integrity of recombinant human interferon-γ Journal of Biological Chemistry. 264: 12179-12186. PMID 2501300 |
0.344 |
|
| 1989 |
Gerrard TL, Dyer DR, Enterline JC, Zoon KC. Products of stimulated monocytes enhance the activity of interferon-γ Journal of Interferon Research. 9: 115-124. PMID 2497195 DOI: 10.1089/Jir.1989.9.115 |
0.486 |
|
| 1989 |
Karasaki Y, Jaken S, Komoriya A, Zoon KC. Phorbol ester and interferon-γ modulation of epidermal growth factor receptors on human amniotic (WISH) cells Journal of Biological Chemistry. 264: 6158-6163. PMID 2495278 |
0.345 |
|
| 1987 |
Attallah AM, Fleisher TA, Hu R, Abdel-Gaffar H, Ibrahim S, Metwali A, Zoon K. Immunological activities of recombinant interferon-alpha 2 and its A fragment. Journal of Interferon Research. 7: 223-9. PMID 3611842 DOI: 10.1089/jir.1987.7.223 |
0.321 |
|
| 1987 |
Zoon KC. Human interferons: structure and function Interferon. 9: 1-12. PMID 2445691 |
0.307 |
|
| 1986 |
Zoon KC, Karasaki Y, Zur Nedden DL, Hu RQ, Arnheiter H. Modulation of epidermal growth factor receptors by human α interferon Proceedings of the National Academy of Sciences of the United States of America. 83: 8226-8230. PMID 3095830 DOI: 10.1073/pnas.83.21.8226 |
0.302 |
|
| 1986 |
Zur Nedden DL, Zoon KC. Radiolabeling of human interferon alphas with 125I-labeled Bolton-Hunter reagent Methods in Enzymology. 276-281. PMID 3020348 DOI: 10.1016/0076-6879(86)19040-9 |
0.478 |
|
| 1986 |
Zoon KC, Nedden DZ, Arnheiter H. [45] Procedures for studying the binding of interferon to human and bovine cells in monolayer culture Methods in Enzymology. 119: 312-315. PMID 2945072 DOI: 10.1016/0076-6879(86)19047-1 |
0.413 |
|
| 1984 |
Ackerman SK, Zur Nedden D, Heintzelman M, Hunkapiller M, Zoon K. Biologic activity in a fragment of recombinant human interferon alpha. Proceedings of the National Academy of Sciences of the United States of America. 81: 1045-7. PMID 6199790 DOI: 10.1073/Pnas.81.4.1045 |
0.386 |
|
| 1984 |
Arnheiter H, Zoon KC. Microinjection of anti-interferon antibodies into cells does not inhibit the induction of an antiviral state by interferon Journal of Virology. 52: 284-287. PMID 6090705 |
0.421 |
|
| 1983 |
Zoon KC, Arnheiter H, Nedden DZ, Fitzgerald DJP, Willingham MC. Human interferon alpha enters cells by receptor-mediated endocytosis Virology. 130: 195-203. PMID 6314645 DOI: 10.1016/0042-6822(83)90127-7 |
0.457 |
|
| 1983 |
Arnheiter H, Ohno M, Smith M, Gutte B, Zoon KC. Orientation of human leukocyte interferon molecule on its cell surface receptor: Carboxyl terminus remains accessible to a monoclonal antibody made against a synthetic interferon fragment Proceedings of the National Academy of Sciences of the United States of America. 80: 2539-2543. PMID 6302694 DOI: 10.1073/Pnas.80.9.2539 |
0.455 |
|
| 1982 |
Zoon KC, Miller D, Zur Nedden D, Hunkapiller MW. Human leukocyte-derived alpha-interferons: Purification and amino-terminal-amino-acid sequence of two components Journal of Interferon Research. 2: 253-260. PMID 6288814 DOI: 10.1089/Jir.1982.2.253 |
0.305 |
|
| 1980 |
Johnston MI, Zoon KC, Friedman RM, De Clercq E, Torrence PF. Oligo(2'-5')adenylate synthetase in human lymphoblastoid cells. Biochemical and Biophysical Research Communications. 97: 375-83. PMID 6162460 DOI: 10.1016/0006-291X(80)90275-2 |
0.358 |
|
| 1980 |
Stewart II WE, Blalock JE, Burke DC, Chany C, Dunnick JK, Falcoff E, Friedman RM, Galasso GJ, Joklik WK, Vilcek JT, Youngner JS, Zoon KC. ANNOUNCEMENT INTERFERON NOMENCLATURE Journal of Interferon Research. 1: vi-vii. DOI: 10.1089/Jir.1980.1.Vi |
0.469 |
|
| 1979 |
Zoon KC, Bridgen PJ, Smith ME. Production of human lymphoblastoid interferon by Namalwa cells cultured in serum-free media Journal of General Virology. 44: 227-229. PMID 501336 DOI: 10.1099/0022-1317-44-1-227 |
0.358 |
|
| 1979 |
Klein F, Ricketts RT, Jones WI, DeArmon IA, Temple MJ, Zoon KC, Bridgen PJ. Large-scale production and concentration of human lymphoid interferon Antimicrobial Agents and Chemotherapy. 15: 420-427. PMID 464569 DOI: 10.1128/Aac.15.3.420 |
0.346 |
|
| 1979 |
Zoon KC, Smith ME, Bridgen PJ, zur Nedden D, Anfinsen CB. Purification and partial characterization of human lymphoblast interferon. Proceedings of the National Academy of Sciences of the United States of America. 76: 5601-5. PMID 293665 DOI: 10.1073/Pnas.76.11.5601 |
0.351 |
|
| Show low-probability matches. |